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Abstract: Allergic contact hypersensitivity to metals is a delayed-type allergy. Although various
metals are known to produce an allergic reaction, nickel is the most frequent cause of metal allergy.
Researchers have attempted to elucidate the mechanisms of metal allergy using animal models and
human patients. Here, the immunological and molecular mechanisms of metal allergy are described
based on the findings of previous studies, including those that were recently published. In addition,
the adsorption and excretion of various metals, in particular nickel, is discussed to further understand
the pathogenesis of metal allergy.
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1. Introduction
Contact dermatitis is usually caused by external exposure of the skin to allergens, such as
metals, chemicals, and plants. Metal allergy is an inflammatory disease categorized as a delayed-type
hypersensitivity (DTH) reaction. Humans come in contact with various metals daily. For example,
metal alloys are widely used in costume jewelry, dental materials, or glasses. Although many
individuals develop a metal allergy, the precise molecular mechanism underlying this allergy
remains unknown.
Some metals cause contact allergic reactions categorized as type IV DTH, in which skin
inflammation is mediated by hapten-specific T cells [1,2]. In this review, the cellular and molecular
mechanisms identified by basic and clinical studies on metal allergy are described. In addition, the
adsorption and excretion of metals in the human body and useful animal models for investigating
metal allergy are reviewed. Furthermore, the adsorption and excretion of metals in the body are
discussed. Finally, the pathogenesis of metal allergy is described with respect to the potential molecular
mechanisms of this immune response.
2. Metal Allergy
Metals, such as gold (Au), silver (Ag), mercury (Hg), nickel (Ni), titanium (Ti), chromium (Cr),
copper (Cu), and cobalt (Co) are ubiquitous in our environment and are widely used in costume jewelry,
coins, mobile phones, and dental materials. Approximately, 10%–15% of the human population suffers
from contact hypersensitivity to metals [1,2]. This allergy is considerably more common in women
than in men, with an approximate population frequency of 10% in women vs. 2% in men [3,4].
Clinically, metal allergy is related to the cause of contact dermatitis, pustulosis palmoplantaris, lichen
planus, dyshidrotic eczema, and burning mouth syndrome [5–8]. Moreover, patients with autoimmune
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conditions, including systemic lupus erythematosus, rheumatoid arthritis, and Sjögren’s syndrome,
have an increased frequency of metal allergy [9].
A previous study indicated that nickel (II) sulfate has the highest sensitization rate and affects
approximately 15% of the population, followed by cobalt chloride and potassium dichromate,
which approximately 5% and 3% of the population, respectively [10]. Nickel allergy is the most
common [2,11], and clinically important condition that is becoming a threat to public health [12,13].
The use of nickel alloys is common in dentistry, and high concentrations of nickel can be found in
food. Nickel-casting alloys are cheap and have favorable physical properties but are prone to corrosion
in the oral environment [14]. Metal allergy is mainly diagnosed by patch testing. Several reports
have demonstrated that the removal of causal metal can successfully improve allergic symptoms.
Therefore, in addition to the metal concentration, a special quality of metal seems to be important for
the pathogenesis of metal allergy [15–17].
Nickel ions released from various alloys are potent allergens or haptens that can trigger skin
inflammation [18–20]. They penetrate the skin and activate epithelial cells that produce various
cytokines or chemokines. The reaction follows complex immune responses that involve the activation of
antigen-presenting cells (APCs) and T cells [21–23]. Some cytokines activate APCs, such as Langerhans
cells (LCs) or dendritic cells (DCs). Activated APCs migrate to the draining lymph nodes where they
present the allergens or haptens to naive CD4-positive T cells. Subsequent re-exposure to the same
allergen or hapten would lead to the activation of hapten-specific T-cells, which subsequently enter
the bloodstream and produce visible signs of hypersensitivity at 48 to 72 h after allergen or hapten
exposure [24]. However, the precise molecular mechanisms that mediate the interactions between
epithelial and immune cells in nickel allergy remain unknown.
3. Animal Models and Molecular Mechanism of Metal Allergy
Many researchers have used animal models to investigate nickel allergy by administrating
adjuvants. For example, nickel chloride (II) is administered twice into mice in combination with
adjuvants, such as incomplete Freund’s adjuvant and complete Freund’s adjuvant and ear swelling is
evaluated for DTH after 48 h [25].
3.1. Keratinocytes and APCs in Ni Allergy Models
Nickel penetrates the skin tissue and activates keratinocytes, leading to the release of certain
cytokines such as interleukin (IL)-1β and tumor necrosis factor alpha. Subsequently, nickel attaches to
the major histocompatibility complex (MHC) molecules on LCs and DCs that are upregulated by the
cytokines from the surrounding keratinocytes. These cytokines control the expression of E-cadherin and
chemokines, including matrix metalloproteinase-9, secondary lymphoid tissue chemokine (SLC), and
macrophage inflammatory protein-3β, that are produced by the APCs [26–29]. Subsequently, the APCs
migrate to draining lymph nodes where they present these haptens to naive T cells. Re-exposure to the
same hapten induces a hypersensitive reaction in an effector phase at the site of exposure (Figure 1).
Several studies have shown that the activation of p38 mitogen-activated protein kinase in
dermal DCs is required to trigger a T cell-mediated immune response in a mouse model of nickel
allergy [30–33]. Ni-activated epithelial DCs or LCs exhibit the upregulation of CD80, CD83, CD86,
and MHC class II [30]. Moreover, nickel plays an important role in the maturation and activation of
immature LCs or DCs in the skin via phosphorylated MAP kinase kinase 6 (MKK6) [31–34]. Therefore,
Ni-stimulated DCs prime activate T cells to induce skin inflammation at the site of exposure to nickel.
However, the injection of short interfering (si) RNAs targeting MKK6 prevents a hypersensitive reaction
after Ni immunization in a mouse model, suggesting that manipulating MKK6 in DCs might be a good
therapeutic strategy for nickel allergy [25].
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Figure 1. A complex mechanism of metal allergy. The sensitization phase begins after nickel exposure 
to the skin. Nickel penetration into the skin results in the production of proinflammatory cytokines 
(TNF-α and IL-1β), TSLP, and chemokines, which induce activation and migration of haptenated 
protein-loaded epidermal and dermal DCs through afferent lymph to the draining lymph nodes. 
Particularly in humans, nickel directly activates the TLR4 pathway in DCs. In the draining lymph 
nodes, haptenated-peptide presentation results in the proliferation, activation and subsequent 
differentiation of hapten-specific T cells. Secretion of cytokines in the draining lymph nodes during 
the sensitization phase contributes to efficient hapten-specific T cell activation, proliferation, and 
differentiation. At the end of this phase, primed specific T cells migrate out of the lymph nodes to the 
skin. In the elicitation phase, the subsequent application of the same hapten leads to uptake by cells, 
which is presented to the recirculating hapten-specific T cells. The activated T cells produce 
inflammatory cytokines and chemokines at the site of exposure that promote an allergic reaction, 
leading to the development of characteristic skin lesions. 
3.2. Critical Role of Toll-Like Receptor 4 in Ni Allergy 
Human toll-like receptor (TLR) 4 has been shown to play a crucial role in the development of 
contact allergy to nickel [35]. TLR4-deficient mice expressing transgenic human TLR4 developed 
contact hypersensitivity to nickel, whereas those expressing mouse TLR4 did not [35]. Although the 
cell type contributing to a TLR4-mediated allergic reaction has not been identified, immune cells such 
as DCs, macrophages, and endothelial cells were found to be associated with the allergic reaction to 
Ni via TLR4 [35]. Ni-induced activation of TLR4 leads to the activation of nuclear factor (NF)-κB, p38, 
and interferon regulatory factor 3, resulting in the induction of multiple proinflammatory cytokines 
that trigger an allergic response. These findings explain why Ni2+, but not other contact allergens, 
directly triggers NF-κB-dependent activation of human DCs [35]. Furthermore, a recent study 
suggested that other metals, including cobalt and palladium, induce IL-8 production in HEK293 cells 
via TLR4/MD2 [36]. Lipopolysaccharides are an important inducer of nickel allergy and enhance the 
allergic response in TLR4-mutant mice [37]. However, TLR4 signaling by keratinocytes controls 
wound healing by inducing CCL5 expression [38]. Keratinocytes are known to produce danger 
signal-induced cytokines or chemokines in the skin tissue [39]. A recent study demonstrated that 
ionized gold is recognized by TLR3. Epithelial TLR3 plays a crucial role in the localized irritation 
reactivity to gold in the skin and mucosa. Therefore, in addition to gold, nickel, copper and mercury 
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cytokines or chemokines in the skin tissue [39]. A recent study demonstrated that ionized gold is
recognized by TLR3. Epithelial TLR3 plays a crucial role in the localized irritation reactivity to gold in
the skin and mucosa. Therefore, in addition to gold, nickel, copper and mercury salts may activate
an innate immune response in keratinocytes [40]. Taken together, these findings reveal a mechanism
of skin contact allergy development and might contribute to the elucidation of novel therapeutic
strategies such as those based on interference with distinct immune detention pathways.
3.3. Thymic Stromal Lymphopoietin and Its Receptor in Ni Allergy
Using a mouse model, a recent study showed that the increased expression of the thymic stromal
lymphopoietin (TSLP) receptor (TSLPR) on DCs plays a key role in triggering an allergic response to
nickel [41]. In this mouse model of nickel allergy, DCs in ear tissues were activated via TSLPR signaling
induced by keratinocyte-derived TSLP. Furthermore, DTH reactions in mice with Ni-induced allergy
were reduced significantly by the injection of a Tslp–siRNA combined with atelocollagen into the ear
skin of the ear [41]. These results suggest that nickel allergy is triggered by a TSLP/TSLPR-mediated
interaction between epithelial and immune cells. TSLP is produced by keratinocytes, the tonsil crypt
epithelium, and bronchial epithelial cells [42,43]. Furthermore, TSLP induces allergic inflammatory
reactions in patients with asthma and atopic dermatitis [42,43].
Although numerous patients develop allergic symptoms against various metals, experimental
animal models of nickel allergy have been widely used to elucidate the molecular mechanisms of metal
allergy. Allergic diseases are multifactorial disorders caused by various factors, such as genetics and
the environment in addition to exposure to metals. Moreover, little is known regarding the molecular
or cellular mechanisms underlying haptenization of metal allergens during an allergic reaction.
CD25+ T cells isolated from peripheral blood of human nickel-allergy patients demonstrated
a limited or no capacity to suppress metal-specific CD4+ and CD8+ T cell responses. In contrast,
CD4+CD25+ T cells from peripheral blood of non-allergic subjects strongly regulate immune responses
to nickel in a cytokine-independent, cell-contact-dependent mechanism. These results indicate that in
healthy individuals CD25+ Treg can control the activation of both naive and effector nickel-specific T
cells [44,45].
Further studies on animal models might reveal the precise mechanism by which metal allergy
promote the clinical application of new therapeutic strategies.
4. Adsorption and Excretion of Metals
Understanding how metals are metabolized in the body is one of the key factors in better
elucidating the process of developing a metal allergy [46]. The accumulation of metals in the body
is influenced by exposure time, absorption medium, tissue distribution, and metal excretion. Nickel
has been well studied among the metals associated with allergy. The biological half-life of nickel is
estimated to range from 17 to 39 h and 20 to 34 h in the urine and plasma, respectively [47]. The
model allows the precise prediction of the state and extent of exposure, which is affected by varying
concentrations of metals in the atmosphere [47].
The investigation using the excised human skin showed that Ni ions are detected to penetrate the
skin using a very sensitive method to quantify the amount of nickel permeating to the skin [48–50].
Although the permeation process is slow with a lag time of approximately 50 h, the rate using aqueous
nickel chloride is increased compared with that in aqueous nickel sulfate [50]. Thus, the selection
of nickel salt is an important consideration when conducting a skin patch test for detecting nickel
permeation to the skin [50].
Absorption of Ni via the gastrointestinal tract by diet remarkably affects the bioavailability
of nickel in the body; approximately 25% of nickel ingested in drinking water after an over-night
fast is absorbed from the intestine and excreted in the urine, whereas only 1% of nickel ingested
is absorbed [51]. The compartmental model and kinetic parameters decrease the uncertainty of
toxicological assessments of human exposures to Ni via drinking water and food [51].
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The other well-studied example is cobalt. Water-soluble cobalt salts are rapidly absorbed from the
small intestine, although the bioavailability of cobalt is limited and highly variable [52]. Cobalt uptake
occurs substantially through the lungs following inhalation and cobalt oxide in dust, and welding
fumes leads to the systemic dissemination of ultrafine particles via the lymph and vascular system,
releasing soluble cobalt ions [52]. After a single dose of cobalt to humans, the concentration of cobalt
in the serum is initially high but decreases rapidly by the tissue uptake, primarily by the liver and
kidney combined with urinary and fecal excretion. Renal excretion is rapid but decreases over the
first few days, followed by a slow phase lasting for several weeks. Therefore, the metal is sustained in
the tissues for several years [53,54]. During the first 24 h, 40% cobalt is eliminated and approximately
70% is eliminated after a week. However, one month later approximately 20% and one year later
approximately 10% remain [55].
The adsorption and excretion of metals in the human body are also controlled by genetic factors.
A genome-wide association study (GWAS) demonstrated single nucleotide polymorphisms associated
with whole blood levels of metals [56]. Eleven metals and trace elements including aluminum,
cadmium, cobalt, copper, chromium, mercury, manganese, molybdenum, nickel, lead, and zinc, were
evaluated in a cohort of 949 individuals by using mass spectrometry. In addition, DNA samples
were also genotyped. This GWAS analysis revealed that two regions, 4q24 and 1q41, are associated
with serum magnesium levels; these regions encode a protein involved in manganese and zinc
transport, SLC39A8 and SLC30A10, respectively. These data revealed metabolic pathways of metals
and suggested that different subsets of individuals are more susceptible to metal toxicity [56].
5. Conclusions and Perspectives
The incidence of allergic diseases has been increasing worldwide. The pathogenesis and
mechanisms of the allergic response is highly complex, and many patients develop refractory disease.
Because metal allergy is caused by materials used in products that are common in our daily life,
chances of triggering the onset of allergic reactions are high. The clinical symptoms of metal allergy
include rashes, swelling, and pain. Molecular pathogenesis of a metal allergy suggests that excess
responses to metals occur via the complicated process of the interactions among the immune system,
epithelial barrier, and homeostatic mechanism. The unique features, adsorption, and the excretion of
metals in the human body complicate the pathogenesis and symptoms of metal allergy. Molecular
mechanisms of metal allergy need to be determined to develop novel therapeutic strategies. Analysis
and characterization of the precise mechanisms could have clinical implications leading to the
development of new diagnostic or treatment methods for metal allergy.
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